METHYL 8-FLUORO-1,2,3,4-TETRAHYDRO-3-(2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)-2-OXO-4-QUINAZOLINEACETATE
UNII SV7PXZ9T3K
Substance Identification & Data
This profile provides standardized clinical and technical data for Methyl 8-fluoro-1,2,3,4-tetrahydro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-oxo-4-quinazolineacetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SV7PXZ9T3K.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 917389-21-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H16F4N2O4 ZOBYBACEALCILX-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Methyl 8-fluoro-1,2,3,4-tetrahydro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-oxo-4-quinazolineacetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.